Document is current
Any future updates will be listed below
-
Authors
Chen, Zining
Zhang, Yuxuan
Fang, Jiacheng
Zheng, Yiyue
Chen, Delong
Yidilisi, Abuduwufuer
Zhang, Xinyi
Liu, Chi
Huang, Jiniu
Ji, Rui
Chen, Jiamu
Chen, Guohui
Lin, Ping
Hu, Yumeng
Xiang, Jianping
Wang, Jian’an
Jiang, Jun https://orcid.org/0000-0001-6926-9516
-
Funding
Funding for this research was provided by:
National Major Science and Technology Projects of China (2023ZD0504100)
National Natural Science Foundation of China (82170332)
Key Research and Development Program of Zhejiang Province (2024C03095)
Transvascular Implantation Devices Research Institute (KY012024002)
- License Information
-
More Information
Article History
Accepted: 13 August 2025
First Online: 6 September 2025
Declarations
:
: Informed consent was obtained from all individual participants for whom identifying information is included in this article.
: Informed consent for participation in the study was duly obtained from all the individual participants involved.
: The research protocol obtained approval from the Medical Ethics Committee of the Second Affiliated Hospital of Zhejiang University and aligned with the international standards for biomedical research involving human subjects, including the Declaration of Helsinki and ICH-GCP guidelines.
: Dr. Jianping Xiang is the principal scientist of ArteryFlow Technology. Dr. Yumeng Hu is the head of cardiac research of ArteryFlow Technology. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
